We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
126
Kennedy Capital Management
Missouri
$3.69M -$354K -2,782 -10%
RIM
127
Redpoint Investment Management
Australia
$3.53M +$3.03M +23,871 New
NI
128
Numeric Investors
Massachusetts
$3.45M +$2.96M +23,300 New
GCP
129
GSA Capital Partners
United Kingdom
$3.33M +$900K +7,082 +46%
AP
130
AHL Partners
United Kingdom
$3.27M -$3.84M -30,178 -58%
UONDDL
131
University of Notre Dame du Lac
Indiana
$3.27M +$317K +2,497 +13%
MSA
132
Mason Street Advisors
Wisconsin
$3.15M -$34.7K -273 -1%
Citadel Advisors
133
Citadel Advisors
Florida
$3.14M -$7.14M -56,198 -73%
PVI
134
Pura Vida Investments
New York
$3.09M +$2.66M +20,909 New
Ohio Public Employees Retirement System (OPERS)
135
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.09M +$4.2K +33 +0.2%
GH
136
GAM Holding
Switzerland
$3.04M +$2.36M +18,575 +929%
PA
137
Profund Advisors
Maryland
$3.03M -$265K -2,082 -9%
BF
138
BOK Financial
Oklahoma
$3.02M -$31.3K -246 -1%
KC
139
Kepos Capital
New York
$2.89M +$777K +6,114 +45%
WG
140
Winton Group
United Kingdom
$2.83M +$2.43M +19,091 New
Two Sigma Advisers
141
Two Sigma Advisers
New York
$2.7M +$1.96M +15,402 +536%
Wolverine Trading
142
Wolverine Trading
Illinois
$2.65M +$2.05M +16,152 +922%
Federated Hermes
143
Federated Hermes
Pennsylvania
$2.57M -$843K -6,632 -28%
BG
144
Bellevue Group
Switzerland
$2.54M -$559K -4,400 -20%
EF
145
Empowered Funds
Pennsylvania
$2.5M +$471K +3,703 +28%
Macquarie Group
146
Macquarie Group
Australia
$2.5M +$547K +4,300 +34%
N
147
Nuveen
North Carolina
$2.48M +$1.59M +12,500 +294%
TCM
148
Tekla Capital Management
Massachusetts
$2.4M -$3.53M -27,741 -63%
Nisa Investment Advisors
149
Nisa Investment Advisors
Missouri
$2.4M -$254K -2,000 -11%
OAC
150
OMERS Administration Corp
Ontario, Canada
$2.38M -$2.01M -15,800 -50%
4 5
6
7 8

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.